Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Janell Seeger"'
Autor:
Thomas M. Woodcock, Terence J. Hadley, F.J. Hendler, Janell Seeger, Geetha Joseph, Morris K, John T. Hamm, Martin S. Blumenreich
Publikováno v:
American Journal of Clinical Oncology. 18:385-388
A total of 35 women with advanced, metastatic breast cancer were treated with combination chemotherapy consisting of folinic acid 500 mg/m 2 over 2 hours administered with 600 mg/m 2 of 5FU at the midpoint of the folinic acid infusion weekly for 6 we
Publikováno v:
Journal of Interventional Cardiology. 8:355-358
While radiation therapy has been known to cause myocardial and pericardial damage, its role in accentuating coronary artery disease in the absence of traditional cardiovascular risk factors has been controversial. As younger patients with treatable c
Autor:
Thomas M. Woodcock, Subash P. Sheth, Daniel M. Sullivan, Martin S. Blumenreich, Eliza J. Sherrill, Kim A. Lalley, Michael J. Kellihan, John T. Hamm, U. Geetha Joseph, Patrick S. Gentile, Janell Seeger
Publikováno v:
Cancer. 71:2828-2832
Background. Hydroxyurea is an S-phase specific drug. Constant exposure of tumor cells with a low S-phase fraction to the agent may result in improved cell kill. Because of its short half-life, a continuous intravenous infusion may result in better tu
Autor:
Jane M. Raymond, Samuel A. Jacobs, Sheri K. Dennison, Janell Seeger, Terrence P. Cescon, John W Wilson, Norman Wolmark, Charles E. Geyer, Sandra M. Swain
Publikováno v:
Investigational new drugs. 25(6)
This was a phase II multi-institutional trial to determine the efficacy and tolerability of gefitinib (Iressatrade) and docetaxel as first-line treatment in patients with metastatic breast cancer. All patients had histologically confirmed breast canc
Autor:
Martin S. Blumenreich, Subash P. Sheth, Carole L. Miller, Elisa S. Farnsley, Michael J. Kellihan, U. Geetha Joseph, John T. Hamm, Janell Seeger, Linda H. Robinson, Pamela C. Hagan, Daniel M. Sullivan, Thomas M. Woodcock
Publikováno v:
American Journal of Clinical Oncology. 17:163-165
Etoposide is more active in small cell lung cancer when given over 5 days than as a single injection. To examine this concept further, we designed this Phase II study in NSCLC using continuous low-dose oral etoposide. We enrolled 19 patients with mea
Autor:
Martin S. Blumenreich, Janell Seeger, Thomas M. Woodcock, Terence J. Hadley, Benjamin Djulbegovic, John T. Hamm, Geetha Joseph
Publikováno v:
American journal of clinical oncology. 16(4)
Twenty patients with relapsed or refractory non-Hodgkin's lymphoma were treated with high-dose chlorambucil (14 mg/m2 every 6 hours for 6 doses) and dexamethasone (40 mg/day for 5 days). There was a 45% response rate with 17% complete responses. The
Publikováno v:
Cancer Investigation. 7:1-6
Nineteen patients with colorectal adencarcinoma, three with cholangiocarcinoma, two with hepatocellular carcinoma, and one with carcinoid were treated with hepatic artery infusion chemotherapy. An implantable pump system was used to deliver floxuridi
Publikováno v:
Medical Clinics of North America. 70:89-94
To date, the therapeutic challenge of improving the poor prognosis of malignant melanoma has not been met by adjuvant therapy for disseminated disease. But the tedious determination of ineffective therapy has closed some lines of research and opened
Autor:
Janell Seeger, Norman E. Liddell, Terence J. Hadley, Marcus F. Stoddard, Daniel M. Sullivan, Joel Kupersmith
Publikováno v:
Journal of the American College of Cardiology. (1):62-69
A reasonably sensitive and specific noninvasive test for doxorubicin cardiotoxicity is needed. In addition, few data exist on the short- and long-term effects of doxorubicin on diastolic filling. To determine if pulsed Doppler indexes of diastolic fi
Publikováno v:
American journal of clinical oncology. 11(6)
Twenty-two patients with metastatic melanoma were treated with a chemotherapy regimen consisting of two cycles of induction therapy with vinblastine, bleomycin, and cisplatin, followed by maintenance therapy with dacarbazine and dibromodulcitol. A 17